“Plans Are Worthless, But Planning Is Everything” - Biotech leaders discuss key challenges in self-commercialization for late-stage assets
In early February, Cello Health Consulting’s Carl Engleman moderated a panel discussion with senior biotech leaders at the LSX World...
